Dr. Jacob (Kobi) Richter, who co-founded Medinol, was the company's Chief Technology Officer and led Medinol's R & D, Manufacturing, Quality Control and Regulatory Affairs departments until recently attaining Emeritus status.
Under his leadership, Medinol fundamentally transformed the interventional cardiology industry through innovation and revolutionary technology. With an extremely cost-efficient manufacturing operation and best-in-class products, Dr. Richter grew Medinol to become a significant international player in the stenting industry, highly reputable for its commitment to promote scientific advances and health.
Prior to founding Medinol in 1993, Dr. Richter co-founded Orbotech, a leading microelectronic product company listed on NASDAQ. He was the company’s head of product development and later director of
marketing and product development. Currently Dr. Richter is a member of Orbotech’s board of directors.
Dr. Richter has also worked as a post-doctoral and research fellow at the Artificial Intelligence Laboratory and Brain Research Department of the Massachusetts Institute of Technology (MIT) and served as head of research and development for the Israeli Air Force.
Dr. Richter has a Ph.D. in Physiology and Pharmacology from Tel Aviv University. He currently serves on the Cardiac Council of Columbia University Medical Center, and on the Advisory Board of the Center for Brains, Minds and Machines (CBMM) in the McGovern Institute for Brain Research at MIT's Department of BrainDepartment of Brain and Cognitive Sciences.